HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carolina Martínez-Laperche Selected Research

Wilms Tumor (Wilm's Tumor)

8/2012Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carolina Martínez-Laperche Research Topics

Disease

9Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 01/2015
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2023 - 08/2012
5Leukemia
09/2018 - 08/2013
4Neoplasms (Cancer)
01/2023 - 11/2014
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2023 - 01/2023
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2022 - 05/2013
3Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 01/2018
2Cytopenia
06/2023 - 10/2022
2Infections
10/2022 - 07/2022
2Disease Progression
10/2022 - 01/2021
2Residual Neoplasm
09/2014 - 08/2012
1Thrombocytopenia (Thrombopenia)
06/2023
1Neutropenia
06/2023
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023
1Cytokine Release Syndrome
01/2022
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2022
1Macrophage Activation Syndrome
01/2022
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2022
1Hemorrhagic Cystitis
01/2022
1Composite Lymphoma
11/2020
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2020
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2018
1Hodgkin Disease (Hodgkin's Disease)
05/2016
1T-Cell Leukemia (Leukemia, T Cell)
05/2013
1Wilms Tumor (Wilm's Tumor)
08/2012

Drug/Important Bio-Agent (IBA)

6Chimeric Antigen ReceptorsIBA
01/2023 - 01/2022
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 09/2018
5Biomarkers (Surrogate Marker)IBA
01/2023 - 11/2014
3Circulating Tumor DNAIBA
01/2023 - 01/2023
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2023 - 10/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
06/2023
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
06/2023
1Prostaglandins FIBA
06/2023
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
06/2023
1Cell-Free Nucleic AcidsIBA
01/2023
1Antifungal AgentsIBA
10/2022
1Thrombopoietin (c-mpl Ligand)IBA
10/2022
1EnzymesIBA
01/2022
1tisagenlecleucelIBA
01/2022
1ElafinIBA
01/2021
1Busulfan (Busulfex)FDA Link
09/2018
116-iodo-3-methylhexadecanoic acid (MIHA)IBA
12/2017
1Minor Histocompatibility AntigensIBA
12/2017
1KIR ReceptorsIBA
05/2016
1LigandsIBA
05/2016
1NucleophosminIBA
08/2013

Therapy/Procedure

10Stem Cell Transplantation
01/2021 - 08/2012
8Hematopoietic Stem Cell Transplantation
10/2022 - 05/2016
7Therapeutics
06/2023 - 05/2013
7Transplantation
06/2023 - 08/2013
1Induction Chemotherapy
06/2023
1Blood Component Removal (Apheresis)
01/2023
1Salvage Therapy
10/2022
1Drug Therapy (Chemotherapy)
01/2021
1Haploidentical Transplantation
09/2018